Study guide
Sensory tests and amblyopia treatment
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Sensory tests and amblyopia treatment
Key Takeaways Explain This Topic AI
Amblyopia requires an appropriate developmental history and exclusion of structural visual loss.
Refractive correction is a core treatment, with patching or atropine selected according to age, severity and response.
Trial-based patching doses and recurrence findings guide care but do not guarantee identical outcomes for every child.
Last updated: October 2026
Diagnostic Tests of Sensory Status
Clinical Test Dissociative Level Method & Optical Principles Interpretation of Findings
Bagolini Striated Glasses Minimal (Most physiological) Lenses etched with micro-striations placed at 45 ∘ 45^\circ 4 5 ∘ OD and 135 ∘ 135^\circ 13 5 ∘ OS. A point light source appears as a perpendicular ray of light ( 135 ∘ 135^\circ 13 5 ∘ OD, 45 ∘ 45^\circ 4 5 ∘ OS). Symmetrical cross ('X') centered on light indicates normal BSV (if orthophoric on cover test) or Harmonious ARC (if manifest tropia on cover test); one streak missing indicates monocular suppression; two separate streaks with two lights indicates uncrossed or crossed diplopia.
Worth 4-Dot Test Moderate Patient wears red-green goggles (Red OD, Green OS) viewing 4 circular lights: 1 red, 2 green, 1 white. 4 dots indicates normal fusion or HARC; 5 dots (2 red, 3 green) indicates diplopia (red to right = uncrossed/esotropia, red to left = crossed/exotropia); 2 red dots indicates left eye suppression; 3 green dots indicates right eye suppression.
Synoptophore (Major Amblyoscope) High Uses front-surface mirrors and + 6.50 D +6.50\text{ D} + 6.50 D lenses to project target slides to each eye at optical infinity. Evaluates Worth's three grades: Grade I (Simultaneous perception: lion in cage); Grade II (Fusion: clown with balloon/flower, tests motor ranges); Grade III (Stereopsis: depth slides). Measures objective vs subjective angles to establish ARC.
Titmus Stereo Fly Contour / Local Vectographic polarized glasses evaluate disparity from 3000 3000 3000 to 40 40 40 arcseconds. Evaluates gross stereo (fly: 3000 " 3000" 3000" ), animal series ( 400 − 100 " 400 - 100" 400 − 100" ), and graded circles ( 800 − 40 " 800 - 40" 800 − 40" ). Prone to false positives due to monocular contour edge cues.
TNO Test Global Red-green anaglyph glasses view random-dot matrices ( 480 480 480 to 15 15 15 arcseconds). Free of monocular contour cues. A child identifying missing discs possesses genuine global stereopsis, but not alone excluding a small-angle deviation.
Frisby Stereotest Real Depth High-precision perspex plates ( 6 , 3 , 1.5 mm 6, 3, 1.5\text{ mm} 6 , 3 , 1.5 mm ) containing printed geometric shapes. Requires no dissociating glasses . Evaluates real depth disparity ( 600 − 15 " 600 - 15" 600 − 15" ). Excellent for toddlers and pre-verbal screening.
Lang Stereotest (I & II) Pan-Orthoscopic Cylindrical lenticular gratings separate left and right eye images. Requires no glasses . Candidate detects car, star, or moon ( 1200 − 200 " 1200 - 200" 1200 − 200" ). Ideal rapid screening test for infant amblyopia.
Amblyopia: Pathophysiology & Evidence-Based Management
Amblyopia is a unilateral (or rarely bilateral) reduction in best-corrected visual acuity that cannot be directly attributed to any structural abnormality of the eye or visual pathways, caused by abnormal visual experience during the critical period of visual development.
Clinical Classifications
Strabismic Amblyopia: Caused by constant unilateral strabismus (typically infantile esotropia). Cortical suppression of the deviating fovea leads to structural and functional disruption of visual cortex processing. Alternation lowers the risk of unilateral strabismic amblyopia but does not exclude coexisting refractive, deprivation or unequal-fixation causes.
Anisometropic Amblyopia: Caused by unequal refractive error between the two eyes. The eye with greater uncorrected ametropia receives a chronically blurred retinal image:
Anisohyperopia: Highly amblyogenic; an interocular difference of ≥ + 1.00 D \ge +1.00\text{ D} ≥ + 1.00 D to + 1.50 D +1.50\text{ D} + 1.50 D is sufficient to induce amblyopia, because accommodation is driven by the less hyperopic eye, leaving the fellow eye blurred at all distances.
Anisoastigmatism: Amblyogenic threshold is ≥ 1.50 D \ge 1.50\text{ D} ≥ 1.50 D to 2.00 D 2.00\text{ D} 2.00 D cylinder difference (meridional amblyopia).
Anisomyopia: Less amblyogenic; requires an interocular difference of ≥ 3.00 D \ge 3.00\text{ D} ≥ 3.00 D to 4.00 D 4.00\text{ D} 4.00 D , because the myopic eye is naturally used for near tasks.
Isometropic (Ametropic) Amblyopia: Bilateral reduction in visual acuity secondary to high, symmetrical uncorrected refractive error in both eyes (hyperopia ≥ + 4.50 D \ge +4.50\text{ D} ≥ + 4.50 D to + 5.00 D +5.00\text{ D} + 5.00 D ; astigmatism ≥ 2.50 D \ge 2.50\text{ D} ≥ 2.50 D ; myopia ≥ − 6.00 D \ge -6.00\text{ D} ≥ − 6.00 D to − 8.00 D -8.00\text{ D} − 8.00 D ).
Stimulus Deprivation Amblyopia: The most severe and rapid form, caused by physical obstruction of the visual axis (dense congenital cataract, complete ptosis, corneal opacity, or prolonged iatrogenic patching). A dense central cataract present at birth requires urgent specialist assessment and an individual early surgical and rehabilitation plan. Unilateral and bilateral cataracts differ; there is no universal age boundary after which treatment is futile.
Neurobiology & The Critical Period
Landmark investigations by David Hubel and Torsten Wiesel elucidated the cellular basis of amblyopia in the visual cortex (striate cortex / V1):
Ocular Dominance Columns: Neurons in layer IVC of primary visual cortex receive monocular inputs segregated into alternating bands from the lateral geniculate nucleus (LGN). Monocular deprivation during the critical period disrupts binocular competitive synaptogenesis:
Axonal arborizations from the normal eye expand dramatically within layer IVC.
Axonal terminals from the deprived eye retract and atrophy.
Cortical neurons throughout layers II, III, V, and VI lose their binocular responsiveness, driven exclusively by the sound eye.
LGN Changes: Histological examination reveals profound cellular shrinkage (atrophy) of cell bodies in both the parvocellular and magnocellular layers receiving input from the deprived eye.
The Critical Period:
Susceptibility Window: Highest in the first 2 − 3 years 2 - 3\text{ years} 2 − 3 years of life; declines gradually until age 7 − 8 years 7 - 8\text{ years} 7 − 8 years .
Plasticity / Recovery Window: Maximum treatment responsiveness occurs under age 7, though PEDIG data confirms meaningful visual recovery can be achieved up to age 12, and in select motivated adolescents up to age 17.
Evidence-Based Management: PEDIG Clinical Protocols
The Pediatric Eye Disease Investigator Group (PEDIG) randomized controlled trials revolutionized the clinical management of amblyopia:
Optical treatment: Correct clinically important refractive error and reassess acuity, alignment and adherence. Improvement may continue over weeks or months; review timing depends on age, severity and deprivation risk rather than a mandatory waiting period for every child.
Moderate amblyopia: PEDIG studied children under seven with acuity 20/40–20/80. Prescribed two-hour daily patching produced similar initial improvement to six-hour patching. Atropine penalisation is another evidence-based option in selected children. Neither regimen guarantees an identical response in every child.
Severe amblyopia: For acuity 20/100–20/400, six-hour patching produced improvement similar to full-time patching in the studied young children. Monitor the fellow eye and review progress. If acuity plateaus on two-hour patching, confirm adherence and diagnosis and consider increasing the prescribed duration.
Near tasks and recurrence: A trial did not show extra benefit from prescribed near rather than distance activities during patching. Recurrence is possible after successful treatment. In children using six to eight hours daily, reducing to two hours before stopping was associated with less recurrence than abrupt cessation; do not convert that finding into a guaranteed 2-to-0 taper effect.
Sources: AAO Amblyopia Preferred Practice Pattern and AAO sensory and motor testing .